Ameriprise’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-97,000
Closed -$18M 4153
2025
Q3
$18M Buy
+97,000
New +$16.6M ﹤0.01% 1478

Other funds holding JNJ

Ameriprise's JNJ Position: Q2 2026 in Review

Ameriprise reduced its Johnson & Johnson (JNJ) stake by 2.7% in Q2 2026, selling an estimated $88M and leaving 13,401,691 shares worth $3.4B. The position accounts for 0.69% of the portfolio, ranked #18.

Ameriprise first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.71B in Q1 2022. 4,685 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Ameriprise held 13,401,691 shares of Johnson & Johnson worth $3.4B as of Q2 2026.
  • Ameriprise sold 377,715 Johnson & Johnson shares in Q2 2026, an estimated $88M.
  • Johnson & Johnson made up 0.69% of Ameriprise's portfolio in Q2 2026, its #18 holding.
  • Ameriprise first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • Ameriprise's Johnson & Johnson position peaked at $3.71B in Q1 2022.
  • 4,685 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.